Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus

American Journal of Surgical Pathology

Volumn 28, Issue 11, 2004, Pages 1466-1473

  Ban, Shinichi ^a,b   Mino, Mari ^a   Nishioka, Norman S ^a   Puricelli, William ^a   Zukerberg, Lawrence R ^a   Shimizu, Michio ^b   Lauwers, Gregory Y ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Barrett's esophagus; Carcinoma; Dysplasia; Histopathology; Photodynamic therapy

Indexed keywords

PHOTOFRIN;

ADENOCARCINOMA; ADULT; AGED; BARRETT ESOPHAGUS; CANCER RISK; CELL PROLIFERATION; CLINICAL ARTICLE; COLUMNAR EPITHELIUM; DYSPLASIA; EPITHELIZATION; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PHOTODYNAMIC THERAPY; REVIEW; SQUAMOUS EPITHELIUM; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; DIHEMATOPORPHYRIN ETHER; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 7044253666     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000141392.91677.7f     Document Type: Review

References (46)

1. Ackroyd R, Brown NJ, Davis MF, et al. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial. Gut. 2000;47:612-617.
2. Bani-Hani K, Sue-Ling H, Johnston D, et al. Barrett's oesophagus: results from a 13-year surveillance programme. Eur J Gastroentenl Hepatol. 2000;12:649-654.
3. Barham CP, Jones RL, Biddlestone LR, et al. Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous re-epithelialisation. Gut. 1997;41:281-284.
4. Barr H, Shepherd NA, Dix A, et al. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet. 1996;348:584-585.
5. Biddlestone LR, Barham CP, Wilkinson SP, et al. The histopathology of treated Barren's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy. Am J Surg Pathol. 1998; 22:239-245.
6. Bremner CG, Lynch VP, Ellis FH Jr. Barrett's esophagus: congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery. 1970;68:209-216.
7. Buttar NS, Wang KK, Sebo TJ, et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology. 2001;120:1630-1639.
8. Dar MS, Goldblum JR, Rice TW, et al. Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma of oesophagectomy? Gut. 2003;52:486-489.
9. Falk GW. Barrett's esophagus. Gastroenterology. 2002;122:1569-1591.
10. Gillen P, Keeling P, Byrne PJ, et al. Experimental columnar metaplasia in the canine oesophagus. Br J Surg. 1988;75:113-115.
11. Goldblum JR, Lauwers GY. Dysplasia arising in Barrett's esophagus: diagnostic pitfalls and natural history. Semin Diagn Pathol. 2002;19:12-19.
12. Gossner L, Stolte M, Sroka R, et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-amino-levulinic acid. Gastroenterology. 1998;114:448-455.
13. Haggitt RC, Tryzelaar J, Ellis FH, et al. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol. 1978; 70:1-5.
14. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol. 1994;25:982-993.
15. Hornick JL, Blount P, Sanchez C, et al. Histological and biological properties of epithelium underneath re-epithelialized squamous islands in Barrett's esophagus [Abstract]. Lab Invest. 2003;83:122.
16. Katz D, Rothstein R, Schned A, et al. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol. 1998;93:536-541.
17. Lewin KJ, Appleman HD. Barrett's esophagus, columnar dysplasia, and adenocarcinoma of the esophagus, In: Atlas of Tumor Pathology, 3rd series, fascicle 18. Tumors of the Esophagus and Stomach. Washington, DC: Armed Forces Institute of Pathology; 1996:99-144.
18. Li H, Walsh TN, O'Dowd G, et al. Mechanisms of columnar metaplasia and squamous regeneration in experimental Barrett's esophagus. Surgery. 1994;115:176-181.
19. McArdle JE, Lewin KJ, Randall G, et al. Distribution of dysplasias and early invasive carcinoma in Barrett's esophagus. Hum Pathol. 1992;23: 479-482.
20. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001;32:368-378.
21. Montgomery E, Goldblum JR, Greenson JK, et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol. 2001;32:379-388.
22. O'Connor JB, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol. 1999;94:2037-2042.
23. Oberg S, DeMeester TR, Peters JH, et al. The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg. 1999;117:572-580.
24. Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc. 2003;58:183-188.
25. Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc. 1999; 49:1-7.
26. Overholt BF, Panjehpour M. Photodynamic therapy for Barrett's esophagus: clinical update. Am J Gastroenterol. 1996;91:1719-1723.
27. Panjehpour M, Overholt BF, Haydek JM, et al. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation. Am J Gastroenterol. 2000;95:2177-2184.
28. Pass HI. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst. 1993;85:443-456.
29. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol. 1988;19:166-178.
30. Reid BJ, Levine DS, Longton G, et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol. 2000;95:1669-1676.
31. Sampliner RE, Fennerty B, Garewal HS. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc. 1996;44:532-535.
32. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol. 2002;97:1888-1895.
33. Schnell TG, Sontag SJ, Chejfec G, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology. 2001;120:1607-1619.
34. Sharma P, Morales TG, Bhattacharyya A, et al. Squamous islands in Barrett's esophagus: what lies underneath? Am J Gastroenterol. 1998;93: 332-335.
35. Sharma P. An update on strategies for eradication of Barrett's mucosa. Am J Med. 2001;111 (suppl 8A):147-152.
36. Singh P, Taylor RH, Colin-Jones DG. Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present. Am J Gastroenterol. 1994;89:349-356.
37. Smith RR, Hamilton SR, Boitnott JK, et al. The spectrum of carcinoma arising in Barrett's esophagus: a clinicopathologic study of 26 patients. Am J Surg Pathol. 1984;8:563-573.
38. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med. 1986;315: 362-371.
39. Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology. 1996;110:614-621.
40. Spechler SJ. Barrett's esophagus. N Engl J Med. 2002;346:836-842.
41. Swisher SG, Deford L, Merriman KW, et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2000;119:1126-1132.
42. Van Laethem JL, Cremer M, Peny MO, et al. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut. 1998;43:747-751.
43. Van Laethem JL, Peny MO, Salmon I, et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut. 2000;46:574-577.
44. Wang KK, Sampliner RE. Mucosal ablation therapy of barrett esophagus. Mayo Clin Proc. 2001;76:433-437.
45. Wang KK. Current status of photodynamic therapy of Barrett's esophagus. Gastrointest Endosc. 1999;49(suppl):20-23.
46. Wolfsen HC, Woodward TA, Raimondo M. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Mayo Clin Proc. 2002;77:1176-1181.